TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SNWV

SANUWAVE Health, Inc.

Healthcare · Medical Devices

4.10$ -2.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns SANUWAVE Health, Inc. (SNWV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.9% of the shares are freely tradable; institutional investors hold 47.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 47.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 71.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 9Mio.

Largest Shareholders

Institutions

Institutions SNWV
Name Stake (%) Shares Change (%) Date
BlackRock Inc 5.60 481,540 -1.8 03/31/2026
Awm Investment Company Inc 5.28 454,550 +0.0 03/31/2026
Praetorian PR LLC 4.07 350,000 +32.1 03/31/2026
Vanguard Capital Management, LLC 4.06 348,874 +0.0 03/31/2026
Opaleye Management Inc 3.56 306,140 -68.8 06/30/2026
Solas Capital Management LLC 3.34 287,514 -2.0 03/31/2026
Stifel Financial Corp 2.93 251,633 +41.9 03/31/2026
UBS Group AG 2.44 210,263 +1,029.2 03/31/2026
Geode Capital Management, LLC 2.00 171,798 +2.7 03/31/2026

Funds

Funds SNWV
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.08 264,933 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?